Skip links

Empowers Kai Medical Laboratory Launches Revenue Generating Program Targeting More Than 500 Texas Schools

U.S. Federal CARES Act Government Funding for COVID-19 Relief in Texas Schools Stands at $17.1B

EMPOWER CLINICS INC. (CSE: CBDT)(Frankfurt:8EC)(OTC PINK: EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centres, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – is pleased to announce that Empowers Kai Medical Laboratory, LLC (“KAI”) has successfully registered with the U.S. Federal CARES Act Program.

“This designation is a monumental revenue catalyst for KAI,” said Steven McAuley, Chairman and CEO of Empower Clinics. “As the world stands amid another tragic wave of COVID-19, mass vaccinations offer a layer of protection, but widespread testing remains a crucial layer of defence. This heightened demand coupled with generous federal funding puts KAI in the best position to earn significant local revenue. We are kickstarting this designation with a pilot project to offer covered testing in 500 Texas schools. I’m confident this is a strong new catalyst to KAI’s positive work in the testing and research sphere.”

KAI Medical Laboratory is a high complexity laboratory accredited by Clinical Laboratory Improvement Amendments (CLIA) and Commission on Office Laboratory Accreditation (COLA) that offers no-cost coronavirus testing (COVID-19). Under the CARES Act and the Families First Coronavirus Relief Act (FFCRA), patients are generally not responsible for the cost of COVID-19 testing and related services, including co-pays or other out-of-pocket costs. There is no out-of-pocket cost for most uninsured patients through the Federal Health Resources and Services Administration (HRSA) Program for COVID-19 Testing, Treatment, and Vaccine Administration. If HRSA covers a patient’s test, KAI will accept reimbursement from HRSA as payment in full.

Yoshi Tyler, Kai Medical Laboratory President, added, “We are thrilled to be part of this program. And more importantly, we will now expand services to our citizens, neighbours, and community with comprehensive testing that is easy, quick, and provides safe results.”

Through KAI’s certifications and registrations with Medicare, Medicaid, private insurance, and now the Federal CARES Act Program, KAI can provide COVID-19 testing at no charge to patients, thereby covering the total cost for those in need of this essential testing. Kai Medical Laboratory has partnered with On Time Mobile Phlebotomy Services, LLC. to expand its reach for school testing initiatives.

Texas schools have received at least $17.1 billion in federal aid over the course of the pandemic, $13.2 billion of which was allocated as part of the March 2020 CARES Act. The CARES Act opens a trove of opportunities for KAI to deliver accessible testing in both Texas and across the country.

ABOUT THE U.S. CARES ACT
The Coronavirus Aid, Relief, and Economic Security (CARES) Act (2020) is a federal program aimed at providing direct economic assistance related to the COVID-19 pandemic for American workers, families, small businesses, and industries. The Act includes direct economic assistance for Americans among other programs focused on addressing issues related to the COVID-19 pandemic.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management. https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

CONTACTS:
Investors:
Steven McAuley CEO 
s.mcauley@empowerclinics.com
604-789-2146

Investors:
Tamara Mason
Business Development & Communications 
t.mason@empowerclinics.com
416-671-5617

SOURCE: Empower Clinics Inc.

Leave a comment